Research in the Kaeberlein Lab is focused on developing therapies for age-associated diseases by targeting the pathways that regulate aging.
|2013-11-14||"mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome" published in Science. Read the UW news release here.|
|2013-11-13||"Preserving Youth: Does Rapamycin Deliver?" published in Science Translational Medicine.|
|2013-10-29||Dr. Kaeberlein to participate in the panel discussion "Aging Research: The Latest Biomedical Perspectives" hosted by the American Federation for Aging Research.|
|2013-10-15||"Yeast replicative aging: A paradigm for defining conserved longevity interventions" published in FEMS Yeast Research.|
|2013-09-30||"Deciphering the role of natural variation in age-related protein homeostasis" published in BMC Biology.|
|2013-08-22||"The ribosomal protein rpl22 controls ribosome composition by directly repressing expression of its own paralog, rpl22l1" published in PLoS Genetics.|
|2013-08-19||Congratulations to Dr. Simon Johnson on his successful Ph.D. thesis defense. We wish him the best as he begins in post-doctoral research with Dr. Yousin Suh at Albert Einstein Medical College.|